Home The Word Brain My Amedeo FAQ Privacy About Flying Publisher   


The Angels Initiative

Stroke prevention


  Ischemic Heart Disease

  Free Subscription


Articles published in J Nucl Med

Retrieve available abstracts of 14 articles:
HTML format



Single Articles


    January 2023
  1. FOX JJ, Mauguen A, Ito K, Gupta D, et al
    Long-term prognostic value of 82Rubidium PET/CT-determined myocardial perfusion and flow reserve in cancer patients.
    J Nucl Med. 2023 Jan 5:jnumed.122.264795. doi: 10.2967/jnumed.122.264795.
    PubMed     Abstract available


    November 2022
  2. MILLER RJH, Kuronuma K, Singh A, Otaki Y, et al
    Explainable Deep Learning Improves Physician Interpretation of Myocardial Perfusion Imaging.
    J Nucl Med. 2022;63:1768-1774.
    PubMed     Abstract available


    October 2022
  3. MILLER RJ, Pieszko K, Shanbhag A, Feher A, et al
    Deep learning coronary artery calcium scores from SPECT/CT attenuation maps improves prediction of major adverse cardiac events.
    J Nucl Med. 2022 Oct 7. pii: jnumed.122.264423. doi: 10.2967/jnumed.122.264423.
    PubMed     Abstract available


    September 2022
  4. SHANBHAG AD, Miller RJH, Pieszko K, Lemley M, et al
    Deep Learning-based Attenuation Correction Improves Diagnostic Accuracy of Cardiac SPECT.
    J Nucl Med. 2022 Sep 22. pii: jnumed.122.264429. doi: 10.2967/jnumed.122.264429.
    PubMed     Abstract available


  5. BAILLY M, Thibault F, Metrard G, Courtehoux M, et al
    Precision of Myocardial Blood Flow and Flow Reserve measurement during CZT-SPECT perfusion imaging processing: intra- and inter-observer variability.
    J Nucl Med. 2022 Sep 15. pii: jnumed.122.264454. doi: 10.2967/jnumed.122.264454.
    PubMed     Abstract available


    July 2022
  6. SPERRY BW, Bateman TM, Akin EA, Bravo PE, et al
    Hot Spot Imaging in Cardiovascular Diseases: An Information Statement from SNMMI, ASNC, and EANM.
    J Nucl Med. 2022 Jul 21. pii: jnumed.122.264311. doi: 10.2967/jnumed.122.264311.
    PubMed    



  7. SNMMI Image of the Year 2022: PET/CT Biomarker Predicts Post-MI Cardiac Remodeling.
    J Nucl Med. 2022;63:16N.
    PubMed    


  8. STENDAHL JC, Kwan JM, Pucar D, Sadeghi MM, et al
    Radiotracers to Address Unmet Clinical Needs in Cardiovascular Imaging, Part 2: Inflammation, Fibrosis, Thrombosis, Calcification, and Amyloidosis Imaging.
    J Nucl Med. 2022;63:986-994.
    PubMed     Abstract available


    May 2022
  9. STENDAHL JC, Kwan JM, Pucar D, Sadeghi MM, et al
    Radiotracers to Address Unmet Clinical Needs in Cardiovascular Imaging, Part 1: Technical Considerations and Perfusion and Neuronal Imaging.
    J Nucl Med. 2022;63:649-658.
    PubMed     Abstract available


    March 2022
  10. LASSEN ML, Byrne C, Sheykhzade M, Wissenberg M, et al
    Sex Differences and Caffeine Impact in Adenosine-Induced Hyperemia.
    J Nucl Med. 2022;63:431-437.
    PubMed     Abstract available


    February 2022
  11. DIEKMANN J, Koenig T, Thackeray JT, Derlin T, et al
    Cardiac Fibroblast Activation in Patients Early After Acute Myocardial Infarction: Integration with Magnetic Resonance Tissue Characterization and Subsequent Functional Outcome.
    J Nucl Med. 2022 Feb 24. pii: jnumed.121.263555. doi: 10.2967/jnumed.121.263555.
    PubMed     Abstract available


    January 2022
  12. DORBALA S
    2021 SNMMI Highlights Lecture: Cardiovascular Track.
    J Nucl Med. 2022;63:11N-16N.
    PubMed     Abstract available


    August 2021
  13. LASSEN ML, Otaki Y, Kavanagh P, Miller RJH, et al
    Simulation of Low-Dose Protocols for Myocardial Perfusion (82)Rb Imaging.
    J Nucl Med. 2021;62:1112-1117.
    PubMed     Abstract available


    April 2021
  14. GHZALLY Y, Imanli H, Smith M, Mahat J, et al
    Metabolic Scar Assessment with (18)F-FDG -PET: Correlation to Ischemic VT Substrate and Successful Ablation Sites.
    J Nucl Med. 2021 Apr 23. pii: jnumed.120.246413. doi: 10.2967/jnumed.120.246413.
    PubMed     Abstract available


Thank you for your interest in scientific medicine.


AMEDEO Ischemic Heart Disease is free of charge.
This policy is made possible thanks to a media sponsorship by Boehringer Ingelheim.

Design: